Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.43% | -255.51% | -7.85% | 88.51% | 3.04% |
| Total Depreciation and Amortization | -0.42% | -10.53% | 7.84% | -5.19% | -3.04% |
| Total Amortization of Deferred Charges | 0.00% | 9.09% | 0.00% | -47.62% | -4.55% |
| Total Other Non-Cash Items | -0.43% | 149.31% | -7.85% | -148.21% | -3.04% |
| Change in Net Operating Assets | 0.43% | -413.44% | 7.84% | -19.22% | -3.04% |
| Cash from Operations | 0.43% | 5.27% | -7.85% | -25.33% | 3.04% |
| Capital Expenditure | 0.44% | -166.51% | -7.86% | 58.54% | 3.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.61% | -141.18% | -7.94% | 87.93% | 3.15% |
| Cash from Investing | 0.45% | -164.64% | -7.86% | 64.87% | 3.04% |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 9.78% | 0.00% | -18.26% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -486.90% | 0.00% | 9.43% | 0.00% |
| Cash from Financing | -0.43% | 1,564.98% | -7.84% | -12.66% | 3.04% |
| Foreign Exchange rate Adjustments | -0.45% | 122.62% | -7.82% | -1,096.32% | -2.86% |
| Miscellaneous Cash Flow Adjustments | 0.00% | 200.00% | -20.00% | -- | -- |
| Net Change in Cash | -0.43% | 217.85% | -7.85% | -24.42% | 3.04% |